Skip to content

Remote Assessment of Disease and Relapse in Major Depressive Disorder

Remote Assessment of Disease and Relapse in Major Depressive Disorder - RADAR-MDD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48543
Enrollment
200
Registered
2018-09-10
Start date
2019-02-12
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression Major depressive disorder

Interventions

None listed

Sponsors

Institute of Psychiatry, Psychology & Neuroscience/South London and Maudsley NHS Foundation Trust, King's College London
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Aged 18 or over * Meet DSM-5 diagnostic criteria for diagnosis of non-psychotic MDD within the past 2 years * Recurrent MDD (a lifetime history of at least 2 episodes of depression * Willing and able to complete self-reported assessments via smartphone. * Able to give informed consent for participation. * Fluent in English, Spanish, Catalan or Dutch language * Existing ownership of Android smartphone or willingness to use an Android smartphone as their only smartphone.

Exclusion criteria

Exclusion criteria: * Lifetime history of bipolar disorder, schizophrenia, MDD with psychotic features, schizoaffective disorders. * Dementia * History of moderate to severe drug or alcohol abuse within 6 months * History of major medical disease which might impact upon the patient*s ability to participate in normal daily activities for more than 2 weeks (e.g. due to likely hospitalisations or other periods of indisposition). * Pregnancy

Design outcomes

Primary

MeasureTime frame
Main endpoint the presence of a new or continuing major depressive episode (IDS-SR & CIDI-SF).

Secondary

MeasureTime frame
self-esteem (RSES), anxiety (GAD7) , quality of life (WSAS), and illness perception (BIPQ), MDD remission (IDS-SR & CIDI-SF).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)